<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=129980757405201&amp;ev=PageView&amp;noscript=1">
     Prescriber's Letter Pharmacist's Letter
Treating H. pylori Infection

On-Demand Webinar


H. Pylori.jpg

You will see big changes in the preferred regimens for Helicobacter pylori due to increasing antibiotic resistance. Triple therapy with a PPI and two antibiotics (Prevpac, etc) may not be as reliable now that clarithromycin resistance exceeds 15% in many parts of North America.

We are pleased to bring you a discussion about the new guidelines for treating H. pylori infection. Our featured panelist is Dr. Monina Pascua, gastroenterologist at The Oregon Clinic. Dr. Pascua, our editors, and other frontline providers will give their perspective on:

  • Why is triple therapy falling out of favor?
  • What are the quadruple therapy options?
  • How does prior macrolide use impact treatment?
  • Is it practical to use bismuth quadruple therapy?
  • How can adherence with H. pylori regimens be improved?

Complete the form to view this webinar now